Joint Independent External Review of the Expanded Programme on Immunization and Vaccine-Preventable Disease Surveillance in Nepal, 23–30 April 2026
13 November 2026
| Publication
Overview
Nepal’s Expanded Programme on Immunization (EPI) continues to serve as one of the country’s most successful and equitable public health interventions, contributing substantially to reductions in child morbidity and mortality over the past three decades. Anchored in the Immunization Act 2072 (2016), which enshrines immunization as a fundamental right, the programme benefits from strong national commitment, a well-established policy framework, and long-standing collaboration with global and national partners.
The 2026 Joint External Review of the Expanded Programme on Immunization and VaccinePreventable Disease (VPD) Surveillance was conducted at a pivotal moment. Nepal has achieved and sustained major immunization milestones, including polio-free status, rubella elimination and re-validation of maternal and neonatal tetanus elimination (MNTE). World Health Organization (WHO)–United Nations Children’s Fund (UNICEF) Estimates of National Immunization Coverage (WUENIC) indicate consistently high national coverage for most antigens, and the number of zerodose children has declined substantially over the past decade. The country has expanded its immunization schedule and strengthened cold chain infrastructure. Nepal has also consistently met or exceeded surveillance indicator standards and has maintained a functional laboratory network capable of supporting surveillance for multiple VPDs.
However, the review identified several systemic vulnerabilities that threaten the sustainability of these gains. The ongoing transition from the WHO-supported surveillance and immunization medical officer (SIMO) network for polio and VPD surveillance to the Ministry of Health and Food Safety (MoHFS) remains a major financing and operational challenge, as partner-supported systems and human resources remain essential to surveillance and programme operations. Subnational performance varies widely, with persistent pockets of under-immunization, irregular outreach services, and inconsistent microplanning. Human resource shortages — particularly at municipal and health facility levels — undermine service quality, data accuracy, and timely reporting. Cold chain systems, while improved, remain uneven, and temperature monitoring is inconsistent. Surveillance performance meets many indicators but shows signs of strain, particularly in outbreak-prone districts and areas with high staff turnover.
The review also found heavy reliance on female community health volunteers, alongside limited formal demand-generation efforts and insufficient use of social and behaviour change (SBC) strategies. Although misinformation is not widespread, it has disrupted vaccine uptake in several districts . The COVID-19 pandemic further strained the system by diverting resources and affecting routine immunization and surveillance activities.
Despite these challenges, the review team observed strong dedication among health workers, robust national-level coordination, and a clear commitment to sustaining immunization achievements. The programme’s strengths — including its legal foundation, national leadership, and technical partnerships — provide a solid platform for addressing identified gaps.
WHO Team
Communicable Diseases,
Immunization & Vaccines Development,
SEARO Regional Office for the South East Asia (RGO),
WHO South-East Asia
Editors
World Health Organization. Regional Office for South-East Asia
Number of pages
197
Reference numbers
ISBN: 978-92-9280-024-6